COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1566: Articles 15651-15660  | Next

The risk of SARS-CoV-2 outbreaks in low prevalence settings following the removal of travel restrictions
Sachak-Patwa, R., Byrne, H. M., Dyson, L., Thompson, R. N.
10.1101/2021.05.21.21257589 — Posted: 2021-05-22
Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2
Parvu, V., Gary, D., Mann, J., Lin, Y.-C., Mills, D., Cooper, L., Andrews, J. C., Manabe, Y., Pekosz, A., Cooper, C. K.
10.1101/2021.05.20.21257181 — Posted: 2021-05-22
A Deep Recurrent Reinforced Learning model to compare the efficacy of targeted local vs. national measures on the spread of COVID-19 in the UK
Dong, T., benedetto, u., Sinha, S., Dimagli, A., Caputo, M., Angelini, G. D.
10.1101/2021.05.21.20248630 — Posted: 2021-05-22 Discussion: Onsite
Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo
Almanza-Reyes, H., Moreno, S., Plascencia-Lopez, I., Alvarado-Vera, M., Patron-Romero, L., Borrego, B., Reyes-Escamilla, A., Valencia-Manzo, D., Brun, A., Pestryakov, A., Bogdanchikova, N.
10.1101/2021.05.20.21256197 — Posted: 2021-05-22
Mechanistic model calibration and the dynamics of the COVID-19 epidemic in the UK (the past, the present and the future)
Willis, M. J., Wright, A., Bramfitt, V., Conn, H., Talyor, R.
10.1101/2021.05.18.21257384 — Posted: 2021-05-22
Predominance of the SARS-CoV-2 lineage P.1 and its sublineage P.1.2 in patients from the metropolitan region of Porto Alegre, Southern Brazil in March 2021: a phylogenomic analysis
Franceschi, V. B., Caldana, G. D., Perin, C., Horn, A., Peter, C., Cybis, G. B., Ferrareze, P. A. G., Rotta, L. N., Cadegiani, F. A., Zimerman, R. A., Thompson, C. E.
10.1101/2021.05.18.21257420 — Posted: 2021-05-22
Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
Studer, F., Petit, J.-L., Engelen, S., Mendoza-Parra, M. A.
10.1101/2021.05.18.21257281 — Posted: 2021-05-22 Discussion: Onsite
Rapid identification of Sars-CoV-2 variants of concern using the portable peakPCR platform
Hosch, S., Bechtold, P., Wagner, P., Ruiz-Serrano, A., Gregorini, M., Siegrist, D., Engler, O., Stark, W. J., Daubenberger, C. A., Schindler, T.
10.1101/2021.05.21.21256124 — Posted: 2021-05-21
Missense variants in human ACE2 modify binding to SARS-CoV-2 Spike
MacGowan, S. A., Barton, M. I., Kutuzov, M., Dushek, O., van der Merwe, P. A., Barton, G. J.
10.1101/2021.05.21.445118 — Posted: 2021-05-21
Structure and dynamics of RNA guanine quadruplexes in SARS-CoV-2 genome. Original strategies against emerging viruses
Miclot, T., Hognon, C., Bignon, E., Terenzi, A., Marazzi, M., Barone, G., MONARI, A.
10.1101/2021.05.20.444918 — Posted: 2021-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).